Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ligand Pharmaceuticals Incorporated    LGND

LIGAND PHARMACEUTICALS INCORPORATED

(LGND)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on LIGAND PHARMACEUTICALS INC
10/30/19 Q3 2019 Earnings Release (Projected)
02/18/20 FY 2019 Earnings Release (Projected)
05/12/20 Q1 2020 Earnings Release (Projected)
08/10/20 Interim 2020 Earnings Release (Projected)
Past events on LIGAND PHARMACEUTICALS INC
09/10/19 | 08:45am H.C. Wainwright Global Investor Conference
07/30/19 | 09:00am Interim 2019 Earnings Call
07/30/19 | 08:00am Interim 2019 Earnings Release
06/06/19 Annual General Meeting
Upcoming sector events for LIGAND PHARMACEUTICALS INC
10/22/19 | 08:00am GALAPAGOS NV : Extraordinary Shareholders Meeting
10/24/19 | 09:00am BIO-TECHNE CORPORATION : Annual General Meeting
10/24/19 | 09:00am ICON PUBLIC LIMITED COMPANY : Q3 2019 Earnings Call
10/24/19 | 04:30pm GILEAD SCIENCES, INC. : Q3 2019 Earnings Call
More events
Past sector events for LIGAND PHARMACEUTICALS INC
10/14/19 | 11:35am IONIS PHARMACEUTICALS, INC. : Oligonucleotide Therapeutics Society Meeting - 'Improved Safety & Tolerability Profile
10/15/19 | 04:20am IONIS PHARMACEUTICALS, INC. : Oligonucleotide Therapeutics Society Meeting
10/15/19 | 05:25am IONIS PHARMACEUTICALS, INC. : Oligonucleotide Therapeutics Society Meeting
10/15/19 | 05:45am IONIS PHARMACEUTICALS, INC. : Oligonucleotide Therapeutics Society Meeting
Annual publications
Annual results2016201720182019 (e)2020 (e)2021 (e)
Sales
M $
Released
Forecast
Spread
109
111
-1,7%
141
140
0,77%
251
245
2,7%

119

127

140
Operating income
(EBITDA)
M $
Released
Forecast
Spread
55,2
66,6
-17%
79,8
83,7
-4,7%
199
195
2,1%

57,0

73,1


Operating profit
(EBIT)
M $
Released
Forecast
Spread
43,9
51,7
-15%
68,1
69,7
-2,3%
164
159
2,8%

9,98

22,9

35,1
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
7,96
27,0
-71%
57,2
50,9
12%
173
258
-33%

835

31,9


Net income
M $
Released
Forecast
Spread
-1,64
16,6
-110%
12,6
36,8
-66%
143
207
-31%

660

24,9


EPS
 $
Released
Forecast
Spread
-0,08
0,76
-111%
0,53
1,58
-66%
5,96
8,75
-32%

32,9

1,50


Announcement Date02/23/201702/21/201802/07/2019

Assessed data source
© 2019 S&P Global Market Intelligence
© 2019 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise